Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Clinical Trials in Texas | 41,989 Studies Near You

Clinical TrialsTexas

Clinical Trials in Texas

Discover 41,989 clinical trials near Texas. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1321-1340 of 41,989 trials

TerminatedAn Outpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Adjunctive Treatment Of Sub-Optimally Controlled Symptoms of SchizophreniaThis study aims to evaluate whether PF-02545920 is safe and effective in the treatment of sub-optimally controlled symptoms of schizophrenia during a 12-week outpatient treatment…NCT01939548·Birmingham, Alabama and 43 others

Find Trials by Condition in Texas

Breast Cancerin Texas Lung Cancerin Texas Prostate Cancerin Texas Colorectal Cancerin Texas Melanomain Texas Leukemiain Texas Lymphomain Texas Pancreatic Cancerin Texas Ovarian Cancerin Texas Brain Cancerin Texas Diabetesin Texas

Data from ClinicalTrials.govTerms

WithdrawnHomoharringtonine in Treating Patients With Refractory Acute Promyelocytic LeukemiaRATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.NCT00030355·Houston, Texas

CompletedA 10-Week Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety DisorderThe purpose of this study is to evaluate the safety and efficacy of an investigational anti-anxiety medication relative to placebo in patients with generalized anxiety disorder…NCT00236015·Mesa, Arizona and 53 others

CompletedSafety and Efficacy of a Hepatitis B Vaccine in Immunosuppressed PatientsThis is a preliminary trial of a Hepatitis B vaccine (Heplisav-B) in medically immunosuppressed patients.NCT04199715·Dallas, Texas

TerminatedAntineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade GliomaRATIONALE: Current therapies for children with recurrent/progressive high grade gliomas provide very limited benefit to the patient.NCT00003535·Houston, Texas

RecruitingTelephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their CaregiversThis clinical trial compares telephone-based physical activity coaching to self monitored physical activity for improving physical function in older adults who are undergoing…NCT06196008·Davis, California and 15 others

TerminatedOpen-Label, Long-Term Treatment Study, to Assess the Long-Term Safety and Tolerability and Efficacy of Neramexane in Patients With Subjective TinnitusThe purpose of this study is to investigate the long-term safety and tolerability and efficacy of neramexane mesylate in the long-term treatment of subjective tinnitus after a…NCT00827008·Tucson, Arizona and 134 others

CompletedSafety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment Naive, HIV-1 and Hepatitis B Co-Infected AdultsThe primary objective of this study is to evaluate the efficacy of fixed-dose combination (FDC) of bictegravir/emtricitabine/ tenofovir alafenamide (B/F/TAF) versus dolutegravir…NCT03547908·Ft. Pierce, Florida and 68 others

RecruitingA Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular CarcinomaThe primary objectives of Cohort A Phase 1b and exploratory expansion are to evaluate the safety and tolerability of TTI-101 orally administered as a single agent to participants…NCT05440708·Birmingham, Alabama and 20 others

CompletedA Study to Test Whether Different Doses of BI 690517 Alone or in Combination With Empagliflozin Improve Kidney Function in People With Chronic Kidney DiseaseThis study is open to adults with chronic kidney disease. People with and without type 2 diabetes can take part in this study.NCT05182840·Mesa, Arizona and 202 others

CompletedA Study to Evaluate Safety and Tolerability of Subcutaneous Doses of MEDI-545 in Subjects With LupusThe primary objective of this study is to evaluate the safety and tolerability of multiple doses of MEDI-545 in subjects with moderately to severely active Lupus.NCT00657189·Anniston, Alabama and 21 others

Not yet recruitingFirst-in-Human Trial of VBC106 in Participants With Advanced Solid TumorsThis is a multicenter, open-label, multiple-dose, FIH Phase 1/2a trial. The Phase 1 portion adopts BOIN design to identify the MTD and/or RP2D with potential backfill cohorts.NCT07686068·Houston, Texas and 3 others

CompletedA Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Ribavirin in Patients With Chronic Hepatitis C (CHC) Previously Treated With PEG-Intron + RibavirinThis study will evaluate the efficacy, safety and tolerability of PEGASYS plus ribavirin in patients with CHC who could not tolerate or were not responsive to 12 weeks of therapy…NCT00087568·Bakersfield, California and 24 others

TerminatedBintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain MetastasesThis phase I/II trial studies the best dose and effect of pimasertib in combination with bintrafusp alfa in treating patients with cancer that has spread to the brain (brain…NCT04789668·Houston, Texas

Not yet recruitingCombination Versus Alone Liposomal Bupivacaine Blocks in Minimally Invasive Thoracic Surgery-1The goal of this clinical trial is to assess how the location of local anesthetic medication affects pain control capabilities in adult patients undergoing thoracic(chest)-only…NCT07254650·Dallas, Texas

Not yet recruitingRAPID: Phase 2 Platform Trial Of Promising Drugs For AYA Patients With R/R Ewing Sarcoma & DSRCTThe goal of this clinical research study is to learn if new anticancer drugs or drug combinations can help to control relapsed/refractory ES, DSRCT, or SRCS.NCT07781891·Houston, Texas

Active not recruitingStudy of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)This is a randomized, active-controlled, open-label study of pembrolizumab given prior to surgery and pembrolizumab in combination with standard of care radiotherapy (with or…NCT03765918·La Jolla, California and 191 others

RecruitingSafety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast CancerThe purpose of this study is to determine the maximum tolerated dose (MTD) of OTS167 administered via oral capsule (PO) to patients with relapsed/refractory locally advanced or…NCT02926690·Norwalk, Connecticut and 7 others

Not yet recruitingA Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1283 in Participants ≥6 Months to <12 Years of AgeThis study will evaluate 2 dose levels of mRNA-1283 in participants ≥6 months to \<12 years to determine the optimal dose level per age group.NCT07808697·Ontario, California and 30 others

CompletedA Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid ArthritisThe purpose of this study is to evaluate the safety and efficacy of ASP015K in moderate to severe rheumatoid arthritis (RA) subjectsNCT01565655·Birmingham, Alabama and 37 others

PreviousPage 67 of 2100Next

Heart Diseasein Texas